CASI — CASI Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for CASI Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	54.2	66.4	48.6	49.9	18.8
Net Total Accounts Receivable
Net Total Receivables	1.29	4.64	9.8	13	10.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	61.5	74	62	73.4	59.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.69	10.8	21.8	13.2	11.6
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	103	128	138	96.2	75.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.95	7.98	13.2	17	16.7
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	29.6	46.2	53.8	51.7	51.1
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	73	81.5	84.5	44.6	24.2
Total Liabilities & Shareholders' Equity	103	128	138	96.2	75.3
Total Common Shares Outstanding
Total Preferred Shares Outstanding